Tsumura & Co. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
110,057
110,438
112,618
114,957
117,882
120,906
Cost of Goods Sold (COGS) incl. D&A
38,788
41,859
45,048
49,457
49,607
49,450
Gross Income
71,269
68,579
67,570
65,500
68,275
71,456
SG&A Expense
48,808
49,087
47,743
49,516
51,224
52,935
EBIT
22,461
19,492
19,827
15,984
17,051
18,521
Unusual Expense
-
1,191
564
7
934
-
Non Operating Income/Expense
5,785
1,846
287
1,258
2,143
918
Interest Expense
186
201
182
144
333
162
Pretax Income
28,118
20,078
18,898
17,184
20,284
19,897
Income Tax
9,911
5,755
6,073
4,446
5,489
5,064
Consolidated Net Income
18,207
14,323
12,825
12,738
14,794
14,833
Net Income
18,050
14,075
12,557
12,489
14,505
14,594
Net Income After Extraordinaries
18,050
14,075
12,557
12,489
14,505
14,594
Net Income Available to Common
18,050
14,075
12,557
12,488
14,504
14,593
EPS (Basic)
255.94
199.58
178.05
179.45
200.54
190.87
Basic Shares Outstanding
71
71
71
70
72
76
EPS (Diluted)
255.94
199.58
178.05
179.45
200.54
190.87
Diluted Shares Outstanding
71
71
71
70
72
76
EBITDA
27,332
24,879
24,886
21,613
23,208
24,883
Non-Operating Interest Income
56
89
97
64
166
507
Minority Interest Expense
157
248
268
249
289
239
Equity in Affiliates (Pretax)
2
44
8
31
324
112

About Tsumura &

View Profile
Address
2-17-11 Akasaka
Tokyo Tokyo 107
Japan
Employees -
Website http://www.tsumura.co.jp
Updated 07/08/2019
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. It manufactures and sells Kampo medicine, a traditional form of medicine in Japan. The company is also involved in the procurement, sorting, production, processing, and storage of botanical raw materials; production and sale of Kampo extract intermediates; and provision of logistics, storage, distribution, and materials handling services.